Botulinum Toxin Type a and Post-Stroke Spasticity of the Upper Limbs

US Neurology - United Kingdom
doi 10.17925/usn.2009.05.01.38
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Erratum To: Botulinum Toxin Type a in Post-Stroke Lower Limb Spasticity: A Multicenter, Double-Blind, Placebo-Controlled Trial

Journal of Neurology
Neurology
2010English

Botulinum Toxin Type a and Electrical Stimulation in the Treatment of Spasticity

The Japanese Journal of Rehabilitation Medicine
2017English

Does Botulinum Toxin Improve the Function of the Patient With Spasticity After Stroke?

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2007English

Botulinum Toxin Dose Reduction Using Electromyographic Control in Patients With Upper Limb Spasticity

Journal of the Neurological Sciences
Neurology
2015English

Budget Impact Analysis of Botulinum Toxin a Therapy for Upper Limb Spasticity in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Correction To: Budget Impact of Botulinum Toxin Treatment for Spasticity After Stroke – A German Perspective

Zeitschrift für Gesundheitswissenschaften
EnvironmentalPublic HealthOccupational Health
2020English

Efficacy of Botulinum Toxin in Modifying Spasticity to Improve Walking and Quality of Life in Post-Stroke Lower Limb Spasticity - A Randomized Double-Blind Placebo Controlled Study

BMC Neurology
MedicineNeurology
2019English

Outcomes of Ambulatory Rehabilitation Programmes Following Botulinum Toxin for Spasticity in Adults With Stroke

Journal of Rehabilitation Medicine
MedicinePhysical TherapySports TherapyRehabilitationSports Science
2014English

Botulinum Toxin Type a Versus Botulinum Toxin Type B for Cervical Dystonia

2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy